Refocusing on Medication Safety: Best Practices for Injection Safety


We learned a lot navigating our way through the global COVID-19 pandemic and as we define what will become the new normal it is imperative that medication safety efforts remain in focus. Healthcare practitioners have steered through disruptions in supplies, medications, personal protective equipment, and more, and continue to cope with staffing challenges and other stressors while striving to provide optimal patient care. Additionally, more than 90% of hospitalized patients receive some form of intravenous (IV) therapy, either by infusion or IV push administration. IV medications are known to be clinically advantageous due to their immediate therapeutic effect and ability to support plasma drug levels, and patients being treated for COVID-19 often require multiple high-alert medications. Unfortunately, these practices are not without risk.

With harmful outcomes at stake, ISMP believes it is essential to provide healthcare practitioners with relevant information to assist them in identifying and managing the risks.

This webinar will focus on the challenges of the global COVID-19 pandemic, how practitioners can prevent medication errors despite this disruption, how to refocus on best practices related to IV push medications in adults, and how these strategies can have additional workflow benefits.

Intended Audience:

  • Pharmacists, Nurses, CRNAs, Anesthesiologists, PAs

  • Medication Safety Officers

  • Pharmacy and Anesthesia Technicians

  • Risk Managers

  • Leaders in Pharmacy and Nursing

Learning Objectives:

Following completion of this activity, participants will be able to:

  1. Identify how stressors, such as the COVID-19 pandemic, challenge medication safety efforts.

  2. Considering pandemic-related disruptions, list strategies to prevent medication errors, including the use of ready-to-administer preparations.

  3. Describe three best practices for the use of IV push medications.

  4. Explain how best practices for IV push medications can provide additional workflow benefits.


Christina Michalek, BSc Pharm, RPh, FASHP, Medication Safety Specialist, ISMP

Michelle Mandrack, MSN, RN, Director of Consulting Services, ISMP



This activity is funded byFresenius Kabi.

CE Accreditation

Pharmacists and Pharmacy Technicians
mastheadThis CE activity is jointly provided by ProCE, LLC and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-21-286-L05-P/T has been assigned to this knowledge-based live CE activity (initial release date December 14, 2021). This CE activity is approved for 1.0 contact hours (0.1 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Successful completion of the online post-test and evaluation atwww.ProCE.comno later than January 14, 2022 is required to receive CE credit. CE credit will be automatically uploaded to NABP/CPE Monitor upon completion of the post-test and evaluation. No partial credit will be given. Conflict of interest disclosures are required of all faculty and shall be provided to all participants at the conference.

This activity has been approved for up to 1.25 California State Nursing contact hours by the provider, Debora Simmons, who is approved by the California Board of Registered Nursing, Provider Number CEP 13677. Credit will only be issued to individuals that are individually registered and attend theentireprogram.